rss
Evid Based Nurs 9:51 doi:10.1136/ebn.9.2.51
  • Treatment

Review: once daily LMWH is as effective as twice daily LMWH for initial treatment of venous thromboembolism


 
 Q Is once daily low molecular weight heparin (LMWH) as effective (for reducing recurrent venous thromboembolism [VTE]) and as safe (with respect to major haemorrhagic events) as twice daily LMWH in the initial treatment of VTE?

METHODS

GraphicData sources:

Cochrane Peripheral Vascular Diseases Specialized Trials Register (up to April 2005), Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library, Issue 1, 2005), Medline (up to April 2005), EMBASE/Excerpta Medica (up to April 2005), and bibliographies of relevant articles.

GraphicStudy selection and assessment:

randomised controlled trials (RCTs) in any language that compared (in an intention to treat analysis) once daily with twice daily use of a fixed dose of subcutaneous LMWH as initial treatment in patients with objectively documented VTE (deep venous thromboembolism [DVT] or pulmonary embolism [PE]). Study quality was assessed using the Jadad scale. Trials without adequate …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article